Effect of CSM's warning about safety of third generation oral contraceptives

Abstract
# General practitioners in England prescribed second generation pills instead {#article-title-2} EDITOR,—On 18 October last year the Committee on Safety of Medicines issued its latest warning on the risk of thromboembolism associated with combined oral contraceptives.1 It did this after becoming aware of three studies indicating that combined oral contraceptives containing desogestrel and gestodene were likely to be associated with around a twofold increase in the risk of thromboembolism when compared with those containing other progestogens. There was insufficient evidence to know …

This publication has 0 references indexed in Scilit: